CommercialCoverageLow impact
07.03.28, Laser Interstitial Thermal Therapy (LITT)
Independence Blue Cross·PA · Neurosurgery, Neurology, Oncology·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Independence Blue Cross reissued its LITT policy (07.03.28) effective 01/01/2026 with no substantive changes to coverage criteria. The policy confirms coverage for three indications: refractory epilepsy, malignant brain tumors (poor surgical candidates), and symptomatic radiation necrosis (poor surgical candidates), all requiring multidisciplinary team approval and MRI compatibility. All other LITT uses remain experimental/investigational and non-covered.
Action Required
By 01/01/2026: Billing team should verify that claims submission for CPT 61736 and 61737 includes proper documentation of medical necessity criteria per policy. No prior authorization requirement is explicitly stated, but ensure claims are coded only for covered indications (refractory epilepsy, malignant brain tumors in poor surgical candidates, or symptomatic radiation necrosis in poor surgical candidates). All other LITT uses will be denied as experimental/investigational. Verify patient MRI compatibility is documented before claim submission to avoid denials.